# Lexamed, Ltd – FDA Inspection, Dec 6, 2018

Source: https://www.keypedia.com/records/fda_inspections/lexamed-ltd/ac414ff2-c5d3-4b44-bc7a-0ee04d90dbf8
Source feed: FDA_Inspections

> FDA inspection 1073550 of Lexamed, Ltd, December 06, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073550
- Company Name: Lexamed, Ltd
- Inspection Date: 2018-12-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Cincinnati District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1328368 - 2026-07-09](https://www.keypedia.com/records/fda_inspections/lexamed-ltd/42936122-cd0a-41e2-8518-842768447376)
- [FDA Inspection 1176430 - 2022-08-04](https://www.keypedia.com/records/fda_inspections/lexamed-ltd/67bf6191-e42c-445a-ba51-e1970bfa2f1b)
- FDA Inspection 955062 - 2015-11-05
- FDA Inspection 572516 - 2009-03-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sarah-e-rhoades/d965990c-15cc-4722-b2d0-aea7206c71b0)

Company: https://www.keypedia.com/companies/lexamed-ltd/b54f148c-75ae-4ec5-aee3-d675b90f3f88

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22